Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Speedel reports promising results for its new renin inhibitors SPP-630 and SPP-635 / News in Context

Feb. 10, 2005

Therapeutic potential of AZD-7009 for common tachyarrhythmias

Feb. 10, 2005

New phase III data on the efficacy of RSD-1235 in atrial arrhythmia

Feb. 10, 2005

Cardioprotective agents in early development at Dongbu Hannong

Feb. 9, 2005

Hydroxyfasudil prodrugs emerge from Schering R&D

Feb. 9, 2005

Pioglitazone reported to decrease carotid artery intimal thickness in obese subjects

Feb. 9, 2005

Cardiovascular drug candidate RUS-3108 enters phase I in Ireland

Feb. 9, 2005

Bosentan reported to improve survival of patients with primary pulmonary hypertension

Feb. 8, 2005

FDA accepts BiDil NDA resubmission

Feb. 8, 2005

Yamanouchi team identifies new P-selectin inhibitors for coronary artery disease

Feb. 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
$Silhouette of head and brainwith fractal art$
ATAI-dyed Lilly tees up in psychedelics, finds $3.8B fit
BioWorld
Rumblings that psychedelic treatments would soon be ready for prime time gained credence aplenty, and shares of Ataibeckley Inc. (NASDAQ:ATAI) ended July 16 at...